Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-02T23:26:53.783Z Has data issue: false hasContentIssue false

12 - Functional gene-linked polymorphic regions in pharmacogenetics

from Part V - Specific psychotropic drugs and disorders

Published online by Cambridge University Press:  20 August 2009

Marco Catalano
Affiliation:
IRCCS H. San Raffaele, Department of Neuropsychiatric Sciences, Milan, Italy
Bernard Lerer
Affiliation:
Hadassah-Hebrew Medical Center, Jerusalem
Get access

Summary

OVERVIEW

Starting from the complexity of neural pathways and their close integration, this chapter focuses on the possible advantages of investigating polymorphisms involved in the regulation of gene expression or in variation of enzymatic activity, using examples related to neurotransmitter pathway modulation (namely, uptake and metabolism). These examples (i.e., serotonin transporter-linked polymorphic region, monoamine oxidase A (MAO-A) promoter region, and catechol-O-methyltransferase (COMT)) are also used to support the hypothesis that quantitative variations of expression and functional levels would be better than structural changes at single receptor sites to identify differences in both treatment response and, likely, psychopathology. The possible influence of the serotonin (5-HT) transporter variants on the efficacy of fluvoxamine, paroxetine, pindolol augmentation, and on the effects of total sleep deprivation, is described in depression. The possible importance of this functional polymorphism in obsessive-compulsive disorder (OCD), stress reactivity and panic disorder (PD) is also discussed. Variations in MAO-A activity in female patients are discussed in relation to the pharmacogenetics of panic disorder, together with some hypotheses regarding the chromosomal location of the gene. Some preliminary results are described linking a functional polymorphism in the coding sequence of the gene COMT and antidepressant response in unipolar depression and bipolar mood disorder. Finally, the expected impact of new approaches (i.e., orphan receptor research, nucleic acid chips, and single nucleotide polymorphisms) is discussed in terms of the advantages and pitfalls (e.g., many new exciting data but also a stronger need for very careful replications and analysis).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×